Two Schemes Response in Multiple Myeloma
Condition(s):Response, Acute Phase; SurvivorshipLast Updated:February 28, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Response, Acute Phase; SurvivorshipLast Updated:February 28, 2024Recruiting
Condition(s):Insomnia Chronic; Anxiety; Depression; Sleep Quality; Life QualityLast Updated:July 19, 2023Enrolling by invitation
Condition(s):Acute Lymphoblastic LeukemiaLast Updated:April 14, 2022Recruiting
Condition(s):Acute Lymphoblastic Leukemia, in Relapse; Chemotherapeutic Toxicity; Minimal Residual DiseaseLast Updated:January 18, 2022Unknown status
Condition(s):Strains; Acute Lymphoblastic Leukemia; SepsisLast Updated:January 4, 2022Unknown status
Condition(s):Acute Lymphoblastic Leukemia, Adult B-CellLast Updated:September 28, 2021Unknown status
Condition(s):Covid19; Pulmonary ComplicationLast Updated:September 22, 2021Completed
Condition(s):Leukemia, Acute; Covid19; Leukemia, LymphoblasticLast Updated:February 9, 2021Completed
Condition(s):Irritable Bowel Syndrome; Sexual DysfunctionLast Updated:September 29, 2022Not yet recruiting
Condition(s):Breast Cancer; Taste Disorders; Dysgeusia; Ageusia; Quality of LifeLast Updated:September 10, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.